• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall GE OEC 9900ESP Elite

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
  Class 2 Device Recall GE OEC 9900ESP Elite see related information
Date Initiated by Firm August 12, 2009
Date Posted January 20, 2010
Recall Status1 Terminated 3 on April 23, 2012
Recall Number Z-0004-2010
Recall Event ID 53491
Product Classification Image-Intensified Fluoroscopic X-Ray System - Product Code JAA
Product GE OEC 9900 Elite ESP

To produce mobile fluoroscopic images of human anatomy.
Code Information All associated serial numbers
Recalling Firm/
Ge Healthcare
384 Wright Brothers Dr
Salt Lake City UT 84116-2862
For Additional Information Contact Deena Pease
Manufacturer Reason
for Recall
A software defect - may result in a false indication and warning on the OEC 9900 Workstation and C-arm display that the X-Ray tube Anode is over-heated. This will also cause the displayed air kerma rate and cumulative air kerma to be inaccurate.
FDA Determined
Cause 2
Radiation Control for Health and Safety Act
Action An Important Electronic Product Radiation Warning letter will be sent to customers identifying the issues, interim solution, and permanent solution. Questions or concerns are to be directed to the GEHC OEC service team at 1-800-874-7378.
Quantity in Commerce 1411 units total
Distribution Nationwide and Canadian Distribution
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.